These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8613966)

  • 1. Effects of wortmannin analogs on bone in vitro and in vivo.
    Sato M; Bryant HU; Dodge JA; Davis H; Matter WF; Vlahos CJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):543-50. PubMed ID: 8613966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the mechanism of phosphatidylinositol 3-kinase inhibition by wortmannin and related analogs.
    Norman BH; Shih C; Toth JE; Ray JE; Dodge JA; Johnson DW; Rutherford PG; Schultz RM; Worzalla JF; Vlahos CJ
    J Med Chem; 1996 Mar; 39(5):1106-11. PubMed ID: 8676346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts.
    Nakamura I; Sasaki T; Tanaka S; Takahashi N; Jimi E; Kurokawa T; Kita Y; Ihara S; Suda T; Fukui Y
    J Cell Physiol; 1997 Aug; 172(2):230-9. PubMed ID: 9258344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.
    Powis G; Bonjouklian R; Berggren MM; Gallegos A; Abraham R; Ashendel C; Zalkow L; Matter WF; Dodge J; Grindey G
    Cancer Res; 1994 May; 54(9):2419-23. PubMed ID: 8162590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application.
    Niikura K; Takeshita N; Takano M
    J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, inhibits osteoclastic bone resorption in vitro.
    Hall TJ; Jeker H; Schaueblin M
    Calcif Tissue Int; 1995 Apr; 56(4):336-8. PubMed ID: 7767847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo.
    Votta BJ; Levy MA; Badger A; Bradbeer J; Dodds RA; James IE; Thompson S; Bossard MJ; Carr T; Connor JR; Tomaszek TA; Szewczuk L; Drake FH; Veber DF; Gowen M
    J Bone Miner Res; 1997 Sep; 12(9):1396-406. PubMed ID: 9286755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
    Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
    J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An orally active cathepsin K inhibitor, furan-2-carboxylic acid, 1-{1-[4-fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), inhibits osteoclast activity in vitro and bone loss in ovariectomized rats.
    Kim MK; Kim HD; Park JH; Lim JI; Yang JS; Kwak WY; Sung SY; Kim HJ; Kim SH; Lee CH; Shim JY; Bae MH; Shin YA; Huh Y; Han TD; Chong W; Choi H; Ahn BN; Yang SO; Son MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):555-62. PubMed ID: 16699068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation.
    Schaller S; Henriksen K; Sveigaard C; Heegaard AM; Hélix N; Stahlhut M; Ovejero MC; Johansen JV; Solberg H; Andersen TL; Hougaard D; Berryman M; Shiødt CB; Sørensen BH; Lichtenberg J; Christophersen P; Foged NT; Delaissé JM; Engsig MT; Karsdal MA
    J Bone Miner Res; 2004 Jul; 19(7):1144-53. PubMed ID: 15176998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.
    Nakamura I; Takahashi N; Sasaki T; Tanaka S; Udagawa N; Murakami H; Kimura K; Kabuyama Y; Kurokawa T; Suda T
    FEBS Lett; 1995 Mar; 361(1):79-84. PubMed ID: 7890044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading.
    Lakkakorpi PT; Wesolowski G; Zimolo Z; Rodan GA; Rodan SB
    Exp Cell Res; 1997 Dec; 237(2):296-306. PubMed ID: 9434625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
    Yates AJ; Oreffo RO; Mayor K; Mundy GR
    J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen inhibits phorbol ester stimulated osteoclastic bone resorption: an effect mediated by calmodulin.
    Williams JP; McKenna MA; Thames AM; McDonald JM
    Biochem Cell Biol; 2000; 78(6):715-23. PubMed ID: 11206583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of new wortmannin esters: potent inhibitors of phosphatidylinositol 3-kinase.
    Creemer LC; Kirst HA; Vlahos CJ; Schultz RM
    J Med Chem; 1996 Dec; 39(25):5021-4. PubMed ID: 8960564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.
    Schultz RM; Merriman RL; Andis SL; Bonjouklian R; Grindey GB; Rutherford PG; Gallegos A; Massey K; Powis G
    Anticancer Res; 1995; 15(4):1135-9. PubMed ID: 7653991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of D-003, a mixture of high-molecular-weight aliphatic acids from sugarcane wax, and pravastatin on bones and osteoclast apoptosis of ovariectomized rats.
    Mendoza S; Noa M; Mas R; Mendoza N
    Drugs Exp Clin Res; 2005; 31(5-6):181-91. PubMed ID: 16425974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.